U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951099) titled 'Quality Of Life in Prostate Cancer Patients Initiating Triptorelin' on Nov. 16.
Brief Summary: Prostate cancer and its treatment, particularly androgen deprivation therapy (ADT) may affect different aspects of a person's quality of life, including physical well-being and daily activities.
The purpose of this study is to evaluate baseline factors that stabilize or improve quality of life in patients with prostate cancer who are initiating triptorelin treatment as ADT, in routine clinical practice.
Participants in this study will be patients with prostate cancer whose treating physician has decided to initiate treatment with triptor...